This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Yue Zhao, PhD
Principal Scientist at Genentech
Speaker

Profile

Dr. Yue Zhao earned her Ph.D in Biochemistry and Molecular Biology from Peking Union Medical School, China. Her graduate work discovered the NOD-like receptors(NAIPs) for recognizing cytosolic bacterial pathogens. She continued working in the innate immunity space and made several phenomenal discoveries, including the identification of the cytosolic receptor for bacterial Endotoxin and the illustration of the mechanism of pyroptosis, through the elegant work of identifying the executor protein GSDMD. After a short postdoctoral study in Genentech, she joined the Biochemical, Cellular and Pharmacology department of Genentech and is currently working on the drug discoveries in diverse therapeutic areas, including malignant Hemes, anti-fibrosis as well as targeting TMEs.